<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03735043</url>
  </required_header>
  <id_info>
    <org_study_id>2017_54</org_study_id>
    <secondary_id>2018-A01089-46</secondary_id>
    <nct_id>NCT03735043</nct_id>
  </id_info>
  <brief_title>Cardiac Output Monitoring by ccNexfin© in Pregnant Women</brief_title>
  <acronym>CoNex</acronym>
  <official_title>Continuous Non-invasive Cardiac Output, an Evaluation of ccNexfin© in a Pregnant Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Lille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Variations of cardiac output are frequent in pregnant women during obstetrical procedures,
      and may participate to poor foetal outcomes through decrease of uteroplacental bloodflow.
      Thus, monitoring maternal cardiac output appears of major interest, as it would open the way
      to early initiation of hemodynamic supportive management.

      The ccNexfin© is a non-invasive hemodynamic monitoring device, whose relevance for continuous
      monitoring of cardiac output has been reported in a non-pregnant population.

      The hypothesis is that ccNexfin© gives acceptable measurement of maternal cardiac output in
      pregnant women.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 2, 2019</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intra-class correlation coefficient between values of supine position cardiac output evaluated simultaneously by transthoracic echocardiography (measured in liters / minute) and ccNexfin © (measured in liters / minute)</measure>
    <time_frame>1 minute after positioning in supine position</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cohen's Kappa coefficient between changes in maternal ejection volume observed from supine position to left lateral position, evaluated by transthoracic echocardiography (in %) and ccNexfin © (in %) respectively, at the 10% threshold of variation</measure>
    <time_frame>Maternal ejection volume in supine position: 1 minute after positioning in supine position Maternal ejection volume in left lateral position: 1 minute after positioning in left lateral position</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cohen's Kappa coefficient between changes in maternal cardiac output observed from supine position to left lateral position, assessed by transthoracic echocardiography (in %) and ccNexfin © (in %) respectively, at the 15% threshold of variation</measure>
    <time_frame>Maternal cardiac output in supine position: 1 minute after positioning in supine position Maternal cardiac output in left lateral position: 1 minute after positioning in left lateral position</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra-class correlation coefficient between left lateral position cardiac output values assessed simultaneously by transthoracic echocardiography (measured in liters / minute) and ccNexfin © (measured in liters / minute)</measure>
    <time_frame>1 minute after positioning in left lateral position</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pearson correlation coefficient between values of supine position maternal cardiac output evaluated by transthoracic echocardiography (measured in liters / minute) and ccNexfin © (measured in liters / minute), respectively</measure>
    <time_frame>1 minute after positioning in supine position</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pearson correlation coefficient between values of left lateral position maternal cardiac output evaluated by transthoracic echocardiography (measured in liters / minute) and ccNexfin © (measured in liters / minute), respectively</measure>
    <time_frame>1 minute after positioning in left lateral position</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Pregnancy</condition>
  <arm_group>
    <arm_group_label>ccNexfin ©</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cardiac output by ccNexfin ©</intervention_name>
    <description>Measurement of cardiac output by ccNexfin © comparatively to transthoracic echocardiography Subjects participating to the study will be simultaneously measured for cardiac output by ccNexfin © and transthoracic echocardiography. Echocardiographic measurements of cardiac output will be blinded to values measured by ccNexfin ©. For each participant, a first measurement of cardiac output will be performed in the supine position and then after 1 minute of strict left lateral position.</description>
    <arm_group_label>ccNexfin ©</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria

          -  Pregnancy &gt; 32 weeks of amenorrhea

          -  Informed consent to participate to the study

          -  Health insurance

        Exclusion Criteria:

          -  Poor echogenicity for Transthoracic echocardiography

          -  Cardiopathy

          -  Difficulties to move

          -  Necessity of strict supine or lateral position

          -  Impossibility to receive information or to give inform consent to participate to the
             study Refusal to sign inform consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin CONSTANS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Lille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Benjamin CONSTANS, MD</last_name>
    <phone>03 20 44 59 69</phone>
    <phone_ext>+33</phone_ext>
    <email>benjamin.constans@chru-lille.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital coeur poumon, CHU</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Benjamin Constant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2019</verification_date>
  <study_first_submitted>September 18, 2018</study_first_submitted>
  <study_first_submitted_qc>November 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2018</study_first_posted>
  <last_update_submitted>October 1, 2019</last_update_submitted>
  <last_update_submitted_qc>October 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pregnancy</keyword>
  <keyword>ccNexfin©</keyword>
  <keyword>cardiac output</keyword>
  <keyword>hemodynamic</keyword>
  <keyword>non-invasive monitoring</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

